Carcinoma in situ of vagina
ICD-10 D07.2 is a billable code used to indicate a diagnosis of carcinoma in situ of vagina.
Carcinoma in situ of the vagina refers to a localized form of cancer where abnormal cells are present in the epithelial layer of the vaginal wall but have not invaded deeper tissues. This condition is often asymptomatic and may be discovered during routine gynecological examinations or screenings. The most common type of carcinoma in situ found in the vagina is squamous cell carcinoma, which can arise from precancerous lesions such as vulvar intraepithelial neoplasia (VIN) or cervical intraepithelial neoplasia (CIN). Surveillance protocols typically involve regular pelvic examinations and Pap smears to monitor for any changes in the vaginal epithelium. The risk of progression to invasive cancer varies, but factors such as the patient's age, immune status, and presence of other risk factors (e.g., HPV infection) can influence this risk. Early detection and intervention are crucial for favorable outcomes, and treatment options may include surgical excision or laser therapy, depending on the extent of the lesion.
Detailed pathology reports, biopsy results, and treatment plans.
Routine screenings, abnormal Pap results, and follow-up for previously diagnosed lesions.
Ensure that all findings are documented clearly to support the diagnosis and treatment plan.
Comprehensive treatment history, including surgical interventions and follow-up care.
Management of patients with a history of cervical or vulvar cancer and monitoring for recurrence.
Collaboration with pathology for accurate staging and grading of lesions.
Used when a biopsy confirms carcinoma in situ and surgical intervention is required.
Pathology report confirming diagnosis and details of the excision.
Gynecologists should ensure accurate coding based on the extent of the lesion excised.
Carcinoma in situ of the vagina is a precancerous condition that requires monitoring and potential treatment to prevent progression to invasive cancer. Early detection and intervention are crucial for positive patient outcomes.
